These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37090575)

  • 1. Associations of Antihypertensive Medication Consumption and Drug-Drug Interaction with Statin and Metformin with Reduced Alzheimer's Disease and Related Dementias Risk among Hypertensive Patients with Mild Cognitive Impairment using High Volume Claims Data.
    Lundin SK; Hu X; Feng J; Lundin KK; Chen Y; Tao C
    Res Sq; 2023 Apr; ():. PubMed ID: 37090575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between risk of Alzheimer's disease and related dementias and angiotensin receptor Ⅱ blockers treatment for individuals with hypertension in high-volume claims data.
    Lundin SK; Hu X; Feng J; Lundin KK; Li L; Chen Y; Schulz PE; Tao C
    EBioMedicine; 2024 Nov; 109():105378. PubMed ID: 39366251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk.
    Barthold D; Joyce G; Diaz Brinton R; Wharton W; Kehoe PG; Zissimopoulos J
    PLoS One; 2020; 15(3):e0229541. PubMed ID: 32130251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin Receptor Blockers Are Associated With a Lower Risk of Progression From Mild Cognitive Impairment to Dementia.
    Deng Z; Jiang J; Wang J; Pan D; Zhu Y; Li H; Zhang X; Liu X; Xu Y; Li Y; Tang Y;
    Hypertension; 2022 Oct; 79(10):2159-2169. PubMed ID: 35766029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive medication classes and risk of incident dementia in primary care patients: a longitudinal cohort study in the Netherlands.
    Schroevers JL; Hoevenaar-Blom MP; Busschers WB; Hollander M; Van Gool WA; Richard E; Van Dalen JW; Moll van Charante EP
    Lancet Reg Health Eur; 2024 Jul; 42():100927. PubMed ID: 38800111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive medications and dementia in older adults with hypertension.
    Orchard SG; Zhou Z; Fravel M; Ryan J; Woods RL; Wolfe R; Shah RC; Murray A; Sood A; Reid CM; Nelson MR; Bellin L; Polkinghorne KR; Stocks N; Ernst ME
    medRxiv; 2024 Aug; ():. PubMed ID: 39252893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies.
    Ding J; Davis-Plourde KL; Sedaghat S; Tully PJ; Wang W; Phillips C; Pase MP; Himali JJ; Gwen Windham B; Griswold M; Gottesman R; Mosley TH; White L; Guðnason V; Debette S; Beiser AS; Seshadri S; Ikram MA; Meirelles O; Tzourio C; Launer LJ
    Lancet Neurol; 2020 Jan; 19(1):61-70. PubMed ID: 31706889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding antihypertensive medication use after living kidney donation through linked national registry and pharmacy claims data.
    Lentine KL; Schnitzler MA; Garg AX; Xiao H; Axelrod D; Tuttle-Newhall JE; Brennan DC; Segev DL
    Am J Nephrol; 2014; 40(2):174-83. PubMed ID: 25196154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Comparative Effectiveness of Monotherapy and Combination Therapies: Impact of Angiotensin Receptor Blockers on the Onset of Alzheimer's Disease.
    Wang Y; Li M; Kazis LE; Xia W
    JAR Life; 2023; 12():35-45. PubMed ID: 37441415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impacts of center and clinical factors in antihypertensive medication use after kidney transplantation.
    Koraishy FM; Yamout H; Naik AS; Zhang Z; Schnitzler MA; Ouseph R; Lam NN; Dharnidharka VR; Axelrod D; Hess GP; Segev DL; Kasiske BL; Lentine KL
    Clin Transplant; 2020 Mar; 34(3):e13803. PubMed ID: 31997429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive Use and the Risk of Alzheimer's Disease and Related Dementias among Older Adults in the USA.
    Pan X; Zhang D; Heo JH; Park C; Li G; Dengler-Crish CM; Li Y; Gu Y; Young HN; Lavender DL; Shi L
    Drugs Aging; 2022 Nov; 39(11):875-886. PubMed ID: 36251143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower dementia risk with different classes of antihypertensive medication in older patients.
    van Middelaar T; van Vught LA; Moll van Charante EP; Eurelings LSM; Ligthart SA; van Dalen JW; van den Born BJH; Richard E; van Gool WA
    J Hypertens; 2017 Oct; 35(10):2095-2101. PubMed ID: 28509727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive Medication Classes and the Risk of Dementia: A Systematic Review and Network Meta-Analysis.
    den Brok MGHE; van Dalen JW; Abdulrahman H; Larson EB; van Middelaar T; van Gool WA; Moll van Charante EP; Richard E
    J Am Med Dir Assoc; 2021 Jul; 22(7):1386-1395.e15. PubMed ID: 33460618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk.
    Liu JC; Hsu YP; Wu SY
    PLoS One; 2016; 11(9):e0162588. PubMed ID: 27632175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of the first hypertension-associated event with medication, compliance and persistence in naïve hypertensive patients after initiating monotherapy.
    Mathes J; Kostev K; Gabriel A; Pirk O; Schmieder RE
    Int J Clin Pharmacol Ther; 2010 Mar; 48(3):173-83. PubMed ID: 20197011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis.
    Lin PJ; Zhong Y; Fillit HM; Chen E; Neumann PJ
    J Am Geriatr Soc; 2016 Aug; 64(8):1549-57. PubMed ID: 27295430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-II stimulating vs. inhibiting antihypertensive drugs and the risk of Alzheimer's disease or related dementia in a large cohort of older patients with colorectal cancer.
    Du XL; Li Z; Schulz PE
    Front Cardiovasc Med; 2023; 10():1136475. PubMed ID: 37215552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association Between the Prevalence, Medication Adherence and Control of Hypertension and the Prevalence of Mild Cognitive Impairment in Rural Northern China: A Cross-Sectional Study.
    Ma LY; He F; Liu S; Wang XD; Gao Y; Shi Z; Niu J; Ji Y
    Patient Prefer Adherence; 2022; 16():493-502. PubMed ID: 35228797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up.
    Du XL; Simpson LM; Osani MC; Yama JM; Davis BR
    J Alzheimers Dis Parkinsonism; 2022; 12(3):. PubMed ID: 35571234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.